Submitted:
19 November 2024
Posted:
20 November 2024
You are already at the latest version
Abstract
Introduction COVID-19 pandemic had a negative impact on mental health in the general population. The fear, stress, and uncertainty surrounding that traumatic pe-riod could have contributed to the aggravation or possible new onset of obsessive-compulsive symptoms. Materials and Methods The COvid Mental hEalth Trial (COMET) is a nationwide project organized by the University of Campania "Luigi Vanvitelli" designed as an observational investigation that aimed to gather data from a representative sample of the Italian general population. The current study is a report from the main project and it focuses on OC symptoms. Results A total sample of N=20,720 took part in the survey. N=2332 individuals had a total OCI-R score greater than or equal to 21 (11.3% of the entire sam-ple), indicating the presence of clinically relevant obsessive compulsive symptoms. By excluding patients with a history of previous mental disorders, we still obtained a high number of individuals with OCI-R greater than or equal to 21 (N=2024), representing 10.3% of the overall sample, possibly in-dicating a new incidence of OC symptoms during the pandemic. Discussion Our study highlights a substantial new incidence of obsessive compulsive symptoms in the general public. Some risk factors or red flags should be paid particular attention to in order to prevent development of OC symptoms during a critical and traumatic event such as the COVID-19 pandemic.
Keywords:
1. Introduction
2. Materials and Methods
3. Results
4. Discussion
5. Limitations
6. Conclusions
Author Contributions
Funding
Informed Consent Statement
Conflicts of Interest
References
- Fiorillo, A.; Sampogna, G.; Giallonardo, V.; Del Vecchio, V.; Luciano, M.; Albert, U.; Carmassi, C.; Carrà, G.; Cirulli, F.; Dell’Osso, B.; et al. Effects of the Lockdown on the Mental Health of the General Population during the COVID-19 Pandemic in Italy: Results from the COMET Collaborative Network. Eur Psychiatry 63, e87. [CrossRef]
- Fiorillo, A.; Gorwood, P. The Consequences of the COVID-19 Pandemic on Mental Health and Implications for Clinical Practice. Eur Psychiatry 63, e32. [CrossRef]
- Pompili, M.; Innamorati, M.; Sampogna, G.; Albert, U.; Carmassi, C.; Carrà, G.; Cirulli, F.; Erbuto, D.; Luciano, M.; Nanni, M.G.; et al. The Impact of Covid-19 on Unemployment across Italy: Consequences for Those Affected by Psychiatric Conditions. J Affect Disord 2022, 296, 59–66. [CrossRef]
- Menculini, G.; Tortorella, A.; Albert, U.; Carmassi, C.; Carrà, G.; Cirulli, F.; Dell’Osso, B.; Luciano, M.; Nanni, M.G.; Pompili, M.; et al. Access to Mental Health Care during the First Wave of the COVID-19 Pandemic in Italy: Results from the COMET Multicentric Study. Brain Sci 2021, 11, 1413. [CrossRef]
- Sampogna, G.; Giallonardo, V.; Del Vecchio, V.; Luciano, M.; Albert, U.; Carmassi, C.; Carrà, G.; Cirulli, F.; Dell’Osso, B.; Menculini, G.; et al. Loneliness in Young Adults During the First Wave of COVID-19 Lockdown: Results From the Multicentric COMET Study. Front Psychiatry 2021, 12, 788139. [CrossRef]
- Albert, U.; Losurdo, P.; Leschiutta, A.; Macchi, S.; Samardzic, N.; Casaganda, B.; de Manzini, N.; Palmisano, S. Effect of SARS-CoV-2 (COVID-19) Pandemic and Lockdown on Body Weight, Maladaptive Eating Habits, Anxiety, and Depression in a Bariatric Surgery Waiting List Cohort. OBES SURG 2021, 31, 1905–1911. [CrossRef]
- Sani, G.; Janiri, D.; Moccia, L.; Albert, U.; Carrà, G.; Carmassi, C.; Cirulli, F.; Dell’Osso, B.; Menculini, G.; Nanni, M.G.; et al. Psychopathological Burden and Coping Strategies among Frontline and Second-Line Italian Healthcare Workers Facing the COVID-19 Emergency: Findings from the COMET Collaborative Network. J Affect Disord 2022, 311, 78–83. [CrossRef]
- de Sousa, G.M.; Tavares, V.D. de O.; de Meiroz Grilo, M.L.P.; Coelho, M.L.G.; de Lima-Araújo, G.L.; Schuch, F.B.; Galvão-Coelho, N.L. Mental Health in COVID-19 Pandemic: A Meta-Review of Prevalence Meta-Analyses. Front Psychol 2021, 12, 703838. [CrossRef]
- Kestel D. Transforming mental health for all: a critical role for specialists. World Psychiatry. 2022;21(3):333-334.
- Pellegrini, L.; Garg, K.; Enara, A.; Gottlieb, D.S.; Wellsted, D.; Albert, U.; Laws, K.R.; Fineberg, N.A. Repetitive Transcranial Magnetic Stimulation (r-TMS) and Selective Serotonin Reuptake Inhibitor-Resistance in Obsessive-Compulsive Disorder: A Meta-Analysis and Clinical Implications. Compr Psychiatry 2022, 118, 152339. [CrossRef]
- Kochar, N.; Ip, S.; Vardanega, V.; Sireau, N.T.; Fineberg, N.A. A Cost-of-Illness Analysis of the Economic Burden of Obsessive-Compulsive Disorder in the United Kingdom. Comprehensive Psychiatry 2023, 127, 152422. [CrossRef]
- Hollander, E.; Stein, D.J.; Fineberg, N.A.; Marteau, F.; Legault, M. Quality of Life Outcomes in Patients with Obsessive-Compulsive Disorder: Relationship to Treatment Response and Symptom Relapse. J Clin Psychiatry 2010, 71, 784–792. [CrossRef]
- Albert, U.; Pellegrini, L.; Maina, G.; Atti, A.-R.; De Ronchi, D.; Rhimer, Z. Suicide in Obsessive-Compulsive Related Disorders: Prevalence Rates and Psychopathological Risk Factors. Journal of Psychopathology 2019, 25, 139–148.
- Benatti, B.; Dell’Osso, B.; Shen, H.; Filippou-Frye, M.; Varias, A.; Sanchez, C.; Jo, B.; Hollander, E.; Fineberg, N.A.; Stein, D.J.; et al. Prevalence and Correlates of Current Suicide Risk in an International Sample of OCD Adults: A Report from the International College of Obsessive-Compulsive Spectrum Disorders (ICOCS) Network and Obsessive Compulsive and Related Disorders Network (OCRN) of the European College of Neuropsychopharmacology. J Psychiatr Res 2021, 140, 357–363. [CrossRef]
- Ruscio, A.M.; Stein, D.J.; Chiu, W.T.; Kessler, R.C. The Epidemiology of Obsessive-Compulsive Disorder in the National Comorbidity Survey Replication. Mol Psychiatry 2010, 15, 53–63. [CrossRef]
- Ten Have M, Tuithof M, van Dorsselaer S, Schouten F, Luik AI, de Graaf R. Prevalence and trends of common mental disorders from 2007-2009 to 2019-2022: results from the Netherlands Mental Health Survey and Incidence Studies (NEMESIS), including comparison of prevalence rates before vs. during the COVID-19 pandemic. World Psychiatry. 2023;22(2):275-285.
- Fineberg, N.A.; Hengartner, M.P.; Bergbaum, C.E.; Gale, T.M.; Gamma, A.; Ajdacic-Gross, V.; Rössler, W.; Angst, J. A Prospective Population-Based Cohort Study of the Prevalence, Incidence and Impact of Obsessive-Compulsive Symptomatology. Int J Psychiatry Clin Pract 2013, 17, 170–178. [CrossRef]
- Am, A.-S.; Cm, G.; Na, F.; E, F.-E.; Bj, S.; Tw, R. Neural Basis of Impaired Safety Signaling in Obsessive Compulsive Disorder. Proceedings of the National Academy of Sciences of the United States of America 2017, 114. [CrossRef]
- Fineberg, N.A.; Pellegrini, L.; Wellsted, D.; Hall, N.; Corazza, O.; Giorgetti, V.; Cicconcelli, D.; Theofanous, E.; Sireau, N.; Adam, D.; et al. Facing the “New Normal”: How Adjusting to the Easing of COVID-19 Lockdown Restrictions Exposes Mental Health Inequalities. J Psychiatr Res 2021, 141, 276–286. [CrossRef]
- Guzick, A.G.; Candelari, A.; Wiese, A.D.; Schneider, S.C.; Goodman, W.K.; Storch, E.A. Obsessive-Compulsive Disorder During the COVID-19 Pandemic: A Systematic Review. Curr Psychiatry Rep 2021, 23, 71. [CrossRef]
- Abba-Aji, A.; Li, D.; Hrabok, M.; Shalaby, R.; Gusnowski, A.; Vuong, W.; Surood, S.; Nkire, N.; Li, X.-M.; Greenshaw, A.J.; et al. COVID-19 Pandemic and Mental Health: Prevalence and Correlates of New-Onset Obsessive-Compulsive Symptoms in a Canadian Province. Int J Environ Res Public Health 2020, 17, 6986. [CrossRef]
- Knowles, K.A.; Olatunji, B.O. Anxiety and Safety Behavior Usage during the COVID-19 Pandemic: The Prospective Role of Contamination Fear. J Anxiety Disord 2021, 77, 102323. [CrossRef]
- Tanir, Y.; Karayagmurlu, A.; Kaya, İ.; Kaynar, T.B.; Türkmen, G.; Dambasan, B.N.; Meral, Y.; Coşkun, M. Exacerbation of Obsessive Compulsive Disorder Symptoms in Children and Adolescents during COVID-19 Pandemic. Psychiatry Res 2020, 293, 113363. [CrossRef]
- Pozza, A.; Ragucci, F.; Angelo, N.L.; Pugi, D.; Cuomo, A.; Garcia-Hernandez, M.D.; Rosa-Alcazar, A.I.; Fagiolini, A.; Starcevic, V. Worldwide Prevalence of Obsessive-Compulsive Symptoms during the COVID-19 Pandemic: A Systematic Review and Meta-Analysis. J Psychiatr Res 2024, 172, 360–381. [CrossRef]
- Homayuni, A. Investigating the Correlation between Perceived Stress and Health Anxiety with Obsessive–Compulsive Disorder and Quality of Life during COVID-19 Pandemic. BMC Psychol 2023, 11, 54. [CrossRef]
- Alateeq, D.A.; Almughera, H.N.; Almughera, T.N.; Alfedeah, R.F.; Nasser, T.S.; Alaraj, K.A. The Impact of the Coronavirus (COVID-19) Pandemic on the Development of Obsessive-Compulsive Symptoms in Saudi Arabia. Saudi Med J 2021, 42, 750–760. [CrossRef]
- Nahidi, M.; Ghalandarzadeh, M.; Sinichi, F.; Sahebzadeh, N.; Eslami, S.; Reihani, H.; Emadzadeh, M.; Fayyazi Bordbar, M.R. Investigating the Psychological Effects of Home Quarantine during the Early Peaks of the COVID-19 Pandemic: A Survey from Iran. Int Clin Psychopharmacol 2023, 38, 136–145. [CrossRef]
- Nicolas, G.-B.M.; Ivana, B.R.; Valeria, S.A.; Hanae, Z.T.J. Effects of the COVID-19 Pandemic on the Prevalence of Obsessive-Compulsive Symptoms among Young Adults in Peru: 10.55131/Jphd/2022/200211. Journal of Public Health and Development 2022, 20, 137–151. [CrossRef]
- Schwartz-Lifshitz, M.; Basel, D.; Lang, C.; Hertz-Palmor, N.; Dekel, I.; Zohar, J.; Gothelf, D. Obsessive Compulsive Symptoms Severity among Children and Adolescents during COVID-19 First Wave in Israel. J Obsessive Compuls Relat Disord 2021, 28, 100610. [CrossRef]
- Tanir, Y.; Karayagmurlu, A.; Kaya, İ.; Kaynar, T.B.; Türkmen, G.; Dambasan, B.N.; Meral, Y.; Coşkun, M. Exacerbation of Obsessive Compulsive Disorder Symptoms in Children and Adolescents during COVID-19 Pandemic. Psychiatry Res 2020, 293, 113363. [CrossRef]
- Khan, Y.S.; Jouda, M.; Albobali, Y.; Osman Abouelseoud, M.; Souid, A.; AlMeraisi, M.J.; Alabdulla, M. COVID-19 Pandemic Fears and Obsessive-Compulsive Symptoms in Adolescents with Pre-Existing Mental Disorders: An Exploratory Cross-Sectional Study. Clin Child Psychol Psychiatry 2022, 27, 89–103. [CrossRef]
- Fineberg, N.A.; Pellegrini, L.; Burkauskas, J.; Clarke, A.; Laws, K.R. Individual Obsessive-Compulsive Traits Are Associated with Poorer Adjustment to the Easing of COVID-19 Restrictions. J Psychiatr Res 2022, 148, 21–26. [CrossRef]
- Frota Lisboa Pereira de Souza, A.M.; Pellegrini, L.; Fineberg, N.A. Cognitive Inflexibility, Obsessive-Compulsive Symptoms and Traits and Poor Post-Pandemic Adjustment. Neuroscience Applied 2024, 3, 104073. [CrossRef]
- Murayama, K.; Nakao, T.; Ohno, A.; Tsuruta, S.; Tomiyama, H.; Hasuzawa, S.; Mizobe, T.; Kato, K.; Kanba, S. Impacts of Stressful Life Events and Traumatic Experiences on Onset of Obsessive-Compulsive Disorder. Front Psychiatry 2020, 11, 561266. [CrossRef]
- Rosso, G.; Albert, U.; Asinari, G.F.; Bogetto, F.; Maina, G. Stressful Life Events and Obsessive-Compulsive Disorder: Clinical Features and Symptom Dimensions. Psychiatry Res 2012, 197, 259–264. [CrossRef]
- Wadsworth, L.P.; Van Kirk, N.; August, M.; Kelly, J.M.; Jackson, F.; Nelson, J.; Luehrs, R. Understanding the Overlap between OCD and Trauma: Development of the OCD Trauma Timeline Interview (OTTI) for Clinical Settings. Curr Psychol 2023, 42, 6937–6947. [CrossRef]
- Giallonardo, V.; Sampogna, G.; Del Vecchio, V.; Luciano, M.; Albert, U.; Carmassi, C.; Carrà, G.; Cirulli, F.; Dell’Osso, B.; Nanni, M.G.; et al. The Impact of Quarantine and Physical Distancing Following COVID-19 on Mental Health: Study Protocol of a Multicentric Italian Population Trial. Front Psychiatry 2020, 11, 533. [CrossRef]
- Foa, E.B.; Huppert, J.D.; Leiberg, S.; Langner, R.; Kichic, R.; Hajcak, G.; Salkovskis, P.M. The Obsessive-Compulsive Inventory: Development and Validation of a Short Version. Psychol Assess 2002, 14, 485–496.
- Lovibond, P.F.; Lovibond, S.H. The Structure of Negative Emotional States: Comparison of the Depression Anxiety Stress Scales (DASS) with the Beck Depression and Anxiety Inventories. Behav Res Ther 1995, 33, 335–343. [CrossRef]
- Thoresen, S.; Tambs, K.; Hussain, A.; Heir, T.; Johansen, V.A.; Bisson, J.I. Brief Measure of Posttraumatic Stress Reactions: Impact of Event Scale-6. Soc Psychiatry Psychiatr Epidemiol 2010, 45, 405–412. [CrossRef]
- Hays, R.D.; DiMatteo, M.R. A Short-Form Measure of Loneliness. J Pers Assess 1987, 51, 69–81. [CrossRef]
- van Spijker, B.A.J.; Batterham, P.J.; Calear, A.L.; Farrer, L.; Christensen, H.; Reynolds, J.; Kerkhof, A.J.F.M. The Suicidal Ideation Attributes Scale (SIDAS): Community-Based Validation Study of a New Scale for the Measurement of Suicidal Ideation. Suicide Life Threat Behav 2014, 44, 408–419. [CrossRef]
- Kilpatrick, D.G.; Resnick, H.S.; Milanak, M.E.; Miller, M.W.; Keyes, K.M.; Friedman, M.J. National Estimates of Exposure to Traumatic Events and PTSD Prevalence Using DSM-IV and DSM-5 Criteria. J Trauma Stress 2013, 26, 537–547. [CrossRef]
- Goldberg, D.P.; Gater, R.; Sartorius, N.; Ustun, T.B.; Piccinelli, M.; Gureje, O.; Rutter, C. The Validity of Two Versions of the GHQ in the WHO Study of Mental Illness in General Health Care. Psychol Med 1997, 27, 191–197. [CrossRef]
- Carver, C.S.; Scheier, M.F.; Weintraub, J.K. Assessing Coping Strategies: A Theoretically Based Approach. Journal of Personality and Social Psychology 1989, 56, 267–283. [CrossRef]
- JASP Team (2024). JASP (Version 0.19.0)[Computer software].
- StataCorp. 2023. Stata Statistical Software: Release 15. College Station, TX: StataCorp LLC.
- Fradkin I, Simpson HB, Dolan RJ, Huppert JD. How computational psychiatry can advance the understanding and treatment of obsessive-compulsive disorder. World Psychiatry. 2023;22(3):472-473.
- Heinz A, Liu S. Challenges and chances for mental health care in the 21st century. World Psychiatry. 2022;21(3):423-424.
- Wampold BE, Flückiger C. The alliance in mental health care: conceptualization, evidence and clinical applications. World Psychiatry. 2023; 22(1):25-41.
- Baltar, F.; Brunet, F.; Ignasi Social Research 2.0: Virtual Snowball Sampling Method Using Facebook. Internet Research 2012, 22. [CrossRef]
- Uyar, B.; Donmezdil, S. Comparison of Healthcare Workers and Non-Healthcare Workers in Terms of Obsessive-Compulsive and Depressive Symptoms during COVID-19 Pandemic: A Longitudinal Case-Controlled Study. Front. Public Health 2023, 11. [CrossRef]
- Hurtado, M.M.; Macías, M.; Morales-Asencio, J.M. A New Form of Checking Obsessive-Compulsive Disorder in Physicians: Another Consequence of the COVID-19 Pandemic. A Case Series. Psychiatry Research Case Reports 2023, 2, 100085. [CrossRef]
- Marchetti, I.; Chiri, L.; Ghisi, M.; Sica, C. Obsessive-Compulsive Inventory-Revised (OCI-R): Presentazione e Indicazioni Di Utilizzo Nel Contesto Italiano. Psicoterapia Cognitiva e Comportamentale 2010, 16, 69–84.
- Luginaah, N.A.; Batung, E.S.; Ziegler, B.R.; Amoak, D.; Trudell, J.P.; Arku, G.; Luginaah, I. The Parallel Pandemic: A Systematic Review on the Effects of the COVID-19 Pandemic on OCD among Children and Adolescents. Int J Environ Res Public Health 2023, 20, 7095. [CrossRef]
| Variable | Total sample N=20,720 |
OCI-R < 21 N=18,388 |
OCI-R ≥ 21 N=2332 |
p-value |
|---|---|---|---|---|
| Gender, female, % (N) | 71 (14,720) | 70.2 (12,916) | 77.4 (1,804) | <0.001 |
| Age, mean (SD) | 40.4 (14.3) | 40.9 (14.3) | 36.6 (14.3) | <0.001 |
| Age group, % (N) | <0.001 | |||
| < 24 years | 15.2 (3151) | 14.0 (2,569) | 25.0 (582) | |
| 24-55 years | 65.2 (13,514) | 65.8 (12,104) | 60.5 (1,410) | |
| 55-65 years | 14.0 (2904) | 14.5 (2,663) | 10.3 (241) | |
| > 65 years | 5.6 (1150) | 5.7 (1,055) | 4.1 (95) | |
| Individuals affected by COVID-19, yes % (N) | 5.2 (1088) | 5.1 (943) | 6.2 (145) | 0.03 |
| People living in severely hit regions, yes % (N) | 31.3 (6485) | 31.7 (5828) | 28.2 (657) | <0.01 |
| University degree, yes % (N) | 62.0 (12,846) | 63.1 (11,616) | 52.7 (1230) | <0.001 |
| Employed, yes % (N) | 70.0 (14,518) | 71.4 (13,131) | 59.5 (1387) | <0.001 |
| Lost job due to pandemic, yes % (N) | 6.3 (1302) | 5.8 (1077) | 9.6 (225) | <0.001 |
| Marital status, single, yes % (N) | 39.1 (8091) | 37.5 (6905) | 50.9 (1186) | <0.001 |
| Any physical disorder, yes % (N) | 14.5 (3014) | 14.1 (2589) | 18.3 (425) | <0.001 |
| Healthcare staff, % (N) | 14 (2907) | 14.5 (2674) | 10 (233) | <0.001 |
| With mental disorder, % (N) | 5.5 (1133) | 4.5 (827) | 13.2 (306) | <0.001 |
| In quarantine, % (N) | 75 (15,592) | 75.8 (13,937) | 71.0 (1655) | <0.001 |
| OCI-R |
Total sample (N=20,720) |
Italian normative scores (N=340)* |
p-value |
Differences between the mean and 95% confidence interval |
| Mean (SD) | Mean (SD) | |||
| OCI-R total score | 10.7 (8.2) | 7.8 (7.6) | <0.001 | 2.9 (2.0 to 3.8) |
| OCI-R washing | 2.5 (2.3) | 0.9 (1.5) | <0.001 | 1.6 (1.3 to 1.8) |
| OCI-R checking | 1.2 (1.7) | 1.3 (2.0) | 0.28 | -0.1 (-0.3 to 0.1) |
| OCI-R ordering | 2.4 (2.3) | 1.9 (2.3) | <0.001 | 0.5 (0.2 to 0.7) |
| OCI-R obsessing | 2.9 (2.6) | 1.6 (2.4) | <0.001 | 1.3 (1.0 to 1.6) |
| OCI-R mental | 0.5 (1.3) | 0.3 (0.9) | <0.001 | 0.2 (0.1 to 0.3) |
| OCI-R hoarding | 1.9 (2.1) | 1.7 (2.1) | 0.81 | 0.2 ( -0.02 to 0.4) |
| Individuals affected by COVID-19 (N=1088) | Healthcare staff (N=2907) | Individuals with mental disorders (N=1133) | Individuals in quarantine (N=15,592) | Italian normative scores (N=340)& | |
|---|---|---|---|---|---|
| OCI-R | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) | Mean (SD) |
| OCI-R total score | 11.5 (9.0)*** | 9.3 (7.5)** | 16.1 (11.0)*** | 10.6 (8.0)*** | 7.8 (7.6) |
| OCI-R washing | 2.7 (2.6)*** | 2.6 (2.5)*** | 2.9 (2.8)*** | 2.5 (2.2)*** | 0.9 (1.5) |
| OCI-R checking | 1.3 (1.7) | 1.1 (1.5) | 1.9 (2.3)*** | 1.2 (1.6) | 1.3 (2.0) |
| OCI-R ordering | 2.5 (2.4)*** | 2.1 (2.2) | 3.3 (3.0)*** | 2.4 (2.8)*** | 1.9 (2.3) |
| OCI-R mental neutralizing | 0.6 (1.5)*** | 0.4 (1.1) | 1.0 (1.9)*** | 0.5 (1.3)* | 0.3 (0.9) |
| OCI-R obsessing | 2.4 (2.7)*** | 1.6 (2.1) | 4.6 (3.4)*** | 2.3 (2.5)*** | 1.6 (2.4) |
| OCI-R hoarding | 2.1 (2.3)* | 1.6 (1.9) | 2.6 (2.6)*** | 1.9 (2.1) | 1.7 (2.1) |
| Characteristic | Total Sample | Individuals affected by COVID-19 (N=1088) |
Healthcare staff (N=2907) | Individuals with mental disorders (N=1133) |
Individuals in quarantine (N=15,592) |
p-value |
|---|---|---|---|---|---|---|
| Clinically significant OCD symptoms (OCI-R≥21) - N (%) |
2,332 (11.3) | 145 (13.3) c | 242 (8.3) a | 308 (27.2) a,b,c | 1668 (10.7) b | <0.001 |
| Clinically significant washing (score≥5) - N (%) | 3,279 (15.8) | 215 (19.8) b | 501 (17.3) | 238 (21.0) a | 2369 (15.2) a,b | <0.001 |
| Clinically significant checking (score≥6) - N (%) | 584 (2.8) | 40 (3.7) b | 74 (2.5) c | 89 (7.9) a,b,c | 405 (2.6) b | <0.001 |
| Clinically significant ordering (score≥6) - N (%) | 2,091 (10.1) | 120 (11) c | 204 (7) b | 217 (19) a,b,c | 1,559 (10) c | <0.001 |
| Clinically significant obsessing (score≥8) - N (%) | 1,210 (5.8) | 80 (7.4) a | 74 (2.5) c | 240 (21.2) a,b,c | 826 (5.3) b | <0.001 |
| Clinically significant mental neutralizing (score≥3) - N (%) | 1,340 (6.5) | 92 (8.5) | 135 (4.6) b | 153 (13.6) a,b | 982 (6.3) a | <0.001 |
| Clinically significant hoarding (score≥6) - N (%) | 1,406 (6.8) | 96 (8.9) c | 137 (4.7) a,c | 149 (13.2) a,b | 1045 (6.7) b,c | <0.001 |
| OCI-R < 21 | OCI-R ≥ 21 | Statistic | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Scale | N | Mean (SD) | N | Mean (SD) | T | p-value | Cohen’s d | ||
| DASS-21 Depression |
18,388 | 11.79 (7.64) | 2,332 | 16.42 (5.22) | -28.45 | < 0.001 | -0.63 | ||
| DASS-21 Anxiety |
18,388 | 6.71 (6.52) | 2,332 | 13.17 (6.30) | -45.18 | < 0.001 | -0.99 | ||
| DASS-21 Stress |
18,388 | 16.13 (7.39) | 2,332 | 17.85 (4.49) | -10.97 | < 0.001 | -0.24 | ||
| IES | 18,388 | 6.95 (5.18) | 2,332 | 7.14 (5.16) | -1.66 | 0.01 | -0.04 | ||
| UCLA | 18,388 | 1.88 (0.54) | 2,332 | 1.92 (0.54) | -3.70 | < 0.001 | -0.08 | ||
| SIDAS | 4,629 | 4.87 (6.59) | 585 | 4.83 (6.94) | 0.14 | 0.89 | 0.01 | ||
| SASS | 18,388 | 5.19 (4.21) | 2,332 | 12.62 (5.26) | -77.94 | < 0.001 | -1.71 | ||
| GHQ | 18,388 | 17.39 (3.12) | 2,332 | 17.93 (3.11) | -7.79 | < 0.001 | -0.17 | ||
| OCI-R ≥ 21 | p-value | Exp(B) | 95% C.I. | |
|---|---|---|---|---|
| Lower | Upper | |||
| Being in one of the most affected Italian regions | 0.022 | 1.131 | 1.018 | 1.256 |
| Age groups (reference: up to 24 years) | ||||
| 24 to 54 years | <0.001 | 1.683 | 1.281 | 2.211 |
| 55 to 64 years | 0.312 | 1.137 | 0.886 | 1.459 |
| Over 65 years | 0.973 | 0.995 | 0.755 | 1.312 |
| UCLA global score | 0.025 | 1.019 | 1.002 | 1.035 |
| Time to exposure (reference: week March 30 – April 8) | ||||
| Week April 15 – April 9 | 0.704 | 1.076 | 0.738 | 1.570 |
| Week April 16- April 22 | 0.753 | 1.046 | 0.788 | 1.390 |
| Week April 23 – April 29 | 0.799 | 1.033 | 0.804 | 1.328 |
| Week April 30 – May 4 | 0.955 | 1.005 | 0.854 | 1.183 |
| Quarantine | 0.836 | 1.050 | 0.660 | 1.671 |
| Mental health professionals | 0.481 | 1.171 | 0.755 | 1.815 |
| COVID-19+ | 0.365 | 0.830 | 0.556 | 1.241 |
| Gender (reference male) | <0.001 | 0.741 | 0.664 | 0.828 |
| COPE: using substance (reference never) | ||||
| COPE: using substance. sometimes | 0.068 | 1.508 | 0.970 | 2.347 |
| COPE: using substance. always | 0.041 | 1.600 | 1.019 | 2.512 |
| Constant | <0.001 | 0.063 | ||
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
